Related references
Note: Only part of the references are listed.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Is There a Role for Lung Ultrasound During the COVID-19 Pandemic?
Gino Soldati et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
Zheyong Huang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
COVID-19 Illness and Heart Failure A Missing Link?
Mandeep R. Mehra et al.
JACC-HEART FAILURE (2020)
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
Juan Meng et al.
EMERGING MICROBES & INFECTIONS (2020)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
Alaa Badawi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Seasonal Influenza Infections and Cardiovascular Disease Mortality
Jennifer L. Nguyen et al.
JAMA CARDIOLOGY (2016)
Lifetime Analysis of Hospitalizations and Survival of Patients Newly Admitted With Heart Failure
Soohun Chun et al.
CIRCULATION-HEART FAILURE (2012)
Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review
Vijaiganesh Nagarajan et al.
HEART (2012)
SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
G. Y. Oudit et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling
Xingang Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Pathophysiologic targets in the early phase of acute heart failure syndromes
M Gheorghiade et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
CM Ferrario et al.
CIRCULATION (2005)
ACE2: from vasopeptidase to SARS virus receptor
AJ Turner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Common causes of troponin elevations in the absence of acute myocardial infarction - Incidence and clinical significance
C Roongsritong et al.
CHEST (2004)
Left ventricular performance in patients with severe acute respiratory syndrome - A 30-day echocardiographic follow-up study
SSL Li et al.
CIRCULATION (2003)
Angiotensin-converting enzyme 2 is an essential regulator of heart function
MA Crackower et al.
NATURE (2002)
Share Paper
